Please enable JavaScript to continue using this application.

Compare $BIO vs $TECH | Chartloom

Compare

$BIO vs $TECH

Bio Rad Laboratories Inc · Bio-Techne Corp

BIO

Bio Rad Laboratories Inc

TECH

Bio-Techne Corp

Compare $BIO vs $TECH

Comparing Bio Rad Laboratories Inc and Bio-Techne Corp

BIOBio Rad Laboratories Inc

TECHBio-Techne Corp

BIOBio Rad Laboratories Inc

Market cap

$9.80B

P/E (TTM)

44.15x

Forward P/E (NTM)

33.67x

Forward P/S (NTM)

3.70x

Rev growth (TTM)

1.4%

YTD performance

19.9%

52W performance

20.9%

FCF yield

3.6%

TECHBio-Techne Corp

Market cap

$11.29B

P/E (TTM)

62.64x

Forward P/E (NTM)

34.64x

Forward P/S (NTM)

8.77x

Rev growth (TTM)

-0.4%

YTD performance

21.5%

52W performance

19.6%

FCF yield

2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIO

TECH

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

TECH

Bio-Techne Corp

Market Cap

BIO$9.80B

TECH$11.29B

Enterprise Value

BIO$10.49B

TECH$11.23B

Price

BIO$366.16

TECH$72.46

P/E Ratio

BIO44.15x

TECH62.64x

P/S Ratio

BIO3.78x

TECH9.29x

EV/Sales

BIO4.05x

TECH9.24x

EV/EBITDA

BIO15.48x

TECH28.63x

P/B Ratio

BIO1.38x

TECH5.39x

P/FCF Ratio

BIO27.75x

TECH42.89x

EV/FCF

BIO29.69x

TECH42.65x

PEG Ratio

BION/A

TECH9.81x

Forward P/E (NTM)

BIO33.67x

TECH34.64x

Forward P/S (NTM)

BIO3.70x

TECH8.77x

Revenue (TTM)

BIO$2.59B

TECH$1.22B

Revenue Growth (YoY)

BIO1.4%

TECH-0.4%

Forward Rev Growth

BIO2.9%

TECH9.8%

Gross Margin (TTM)

BIO51.9%

TECH66.2%

Operating Margin (TTM)

BIO1.8%

TECH20.7%

EBITDA Margin (TTM)

BIO9.1%

TECH31.6%

Net Margin (TTM)

BIO8.6%

TECH15.0%

FCF Margin (TTM)

BIO13.6%

TECH21.7%

Net Income (TTM)

BIO$222M

TECH$182M

FCF (TTM)

BIO$353M

TECH$263M

EPS (TTM)

BIO$8.29

TECH$1.16

ROE (TTM)

BIO3.1%

TECH8.9%

ROA (TTM)

BIO2.2%

TECH7.1%

ROIC (TTM)

BIO2.7%

TECH8.0%

Cash

BIO$517M

TECH$265M

Debt

BIO$1.20B

TECH$200M

Net Cash/Debt

BIO$-687M

TECH$65M

Current Ratio (TTM)

BIO3.14x

TECH4.55x

Quick Ratio (TTM)

BIO2.18x

TECH3.35x

Debt/Equity (TTM)

BIO0.17x

TECH0.09x

Debt/Assets (TTM)

BIO0.0%

TECH0.0%

Interest Coverage (TTM)

BION/A

TECHN/A

Net Debt/EBITDA (TTM)

BIO0.00x

TECH0.00x

Beta

BIO1.07

TECH1.29

52W Performance

BIO20.9%

TECH19.6%

YTD Performance

BIO19.9%

TECH21.5%

% from 52W High

BIO-7.6%

TECH-0.3%

% from 52W Low

BIO54.7%

TECH67.7%

Asset Turnover (TTM)

BIO0.26x

TECH0.48x

FCF Yield (TTM)

BIO3.6%

TECH2.3%

Earnings Yield (TTM)

BIO2.3%

TECH1.6%

Dividend Yield (TTM)

BION/A

TECH0.4%

Rule of 40

BIO15.0

TECH21.3

EV/GP/RG

BIO1.18

TECH2.28

Ticker research

View BIO research View TECH research

Metric	BIO Bio Rad Laboratories Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$9.80B	$11.29B
Enterprise Value	$10.49B	$11.23B
Price	$366.16	$72.46
P/E Ratio	44.15x	62.64x
P/S Ratio	3.78x	9.29x
EV/Sales	4.05x	9.24x
EV/EBITDA	15.48x	28.63x
P/B Ratio	1.38x	5.39x
P/FCF Ratio	27.75x	42.89x
EV/FCF	29.69x	42.65x
PEG Ratio	N/A	9.81x
Forward P/E (NTM)	33.67x	34.64x
Forward P/S (NTM)	3.70x	8.77x
Revenue & Growth
Revenue (TTM)	$2.59B	$1.22B
Revenue Growth (YoY)	1.4%	-0.4%
Forward Rev Growth	2.9%	9.8%
Profitability
Gross Margin (TTM)	51.9%	66.2%
Operating Margin (TTM)	1.8%	20.7%
EBITDA Margin (TTM)	9.1%	31.6%
Net Margin (TTM)	8.6%	15.0%
FCF Margin (TTM)	13.6%	21.7%
Net Income (TTM)	$222M	$182M
FCF (TTM)	$353M	$263M
EPS (TTM)	$8.29	$1.16
ROE (TTM)	3.1%	8.9%
ROA (TTM)	2.2%	7.1%
ROIC (TTM)	2.7%	8.0%
Financial Health
Cash	$517M	$265M
Debt	$1.20B	$200M
Net Cash/Debt	$-687M	$65M
Current Ratio (TTM)	3.14x	4.55x
Quick Ratio (TTM)	2.18x	3.35x
Debt/Equity (TTM)	0.17x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.29
52W Performance	20.9%	19.6%
YTD Performance	19.9%	21.5%
% from 52W High	-7.6%	-0.3%
% from 52W Low	54.7%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.48x
FCF Yield (TTM)	3.6%	2.3%
Earnings Yield (TTM)	2.3%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	15.0	21.3
EV/GP/RG	1.18	2.28
Ticker research	View BIO research	View TECH research

Valuation

P/E Ratio

BIO

44.15x

TECH

62.64x

P/S Ratio

BIO

3.78x

TECH

9.29x

EV/FCF

BIO

29.69x

TECH

42.65x

Growth & revenue

Revenue Growth TTM

BIO

1.4%

TECH

-0.4%

Forward Revenue Growth

TECH

9.8%

BIO

2.9%

Profitability & performance

Gross Margin

TECH

66.2%

BIO

51.9%

ROE

TECH

8.9%

BIO

3.1%

FCF Yield %

BIO

3.6%

TECH

2.3%

52-Week Performance

BIO

20.9%

TECH

19.6%

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

TECH

Bio-Techne Corp

Market Cap

BIO$9.80B

TECH$11.29B

Enterprise Value

BIO$10.49B

TECH$11.23B

Price

BIO$366.16

TECH$72.46

P/E Ratio

BIO44.15x

TECH62.64x

P/S Ratio

BIO3.78x

TECH9.29x

EV/Sales

BIO4.05x

TECH9.24x

EV/EBITDA

BIO15.48x

TECH28.63x

P/B Ratio

BIO1.38x

TECH5.39x

P/FCF Ratio

BIO27.75x

TECH42.89x

EV/FCF

BIO29.69x

TECH42.65x

PEG Ratio

BION/A

TECH9.81x

Forward P/E (NTM)

BIO33.67x

TECH34.64x

Forward P/S (NTM)

BIO3.70x

TECH8.77x

Revenue (TTM)

BIO$2.59B

TECH$1.22B

Revenue Growth (YoY)

BIO1.4%

TECH-0.4%

Forward Rev Growth

BIO2.9%

TECH9.8%

Gross Margin (TTM)

BIO51.9%

TECH66.2%

Operating Margin (TTM)

BIO1.8%

TECH20.7%

EBITDA Margin (TTM)

BIO9.1%

TECH31.6%

Net Margin (TTM)

BIO8.6%

TECH15.0%

FCF Margin (TTM)

BIO13.6%

TECH21.7%

Net Income (TTM)

BIO$222M

TECH$182M

FCF (TTM)

BIO$353M

TECH$263M

EPS (TTM)

BIO$8.29

TECH$1.16

ROE (TTM)

BIO3.1%

TECH8.9%

ROA (TTM)

BIO2.2%

TECH7.1%

ROIC (TTM)

BIO2.7%

TECH8.0%

Cash

BIO$517M

TECH$265M

Debt

BIO$1.20B

TECH$200M

Net Cash/Debt

BIO$-687M

TECH$65M

Current Ratio (TTM)

BIO3.14x

TECH4.55x

Quick Ratio (TTM)

BIO2.18x

TECH3.35x

Debt/Equity (TTM)

BIO0.17x

TECH0.09x

Debt/Assets (TTM)

BIO0.0%

TECH0.0%

Interest Coverage (TTM)

BION/A

TECHN/A

Net Debt/EBITDA (TTM)

BIO0.00x

TECH0.00x

Beta

BIO1.07

TECH1.29

52W Performance

BIO20.9%

TECH19.6%

YTD Performance

BIO19.9%

TECH21.5%

% from 52W High

BIO-7.6%

TECH-0.3%

% from 52W Low

BIO54.7%

TECH67.7%

Asset Turnover (TTM)

BIO0.26x

TECH0.48x

FCF Yield (TTM)

BIO3.6%

TECH2.3%

Earnings Yield (TTM)

BIO2.3%

TECH1.6%

Dividend Yield (TTM)

BION/A

TECH0.4%

Rule of 40

BIO15.0

TECH21.3

EV/GP/RG

BIO1.18

TECH2.28

Ticker research

View BIO research View TECH research

Metric	BIO Bio Rad Laboratories Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$9.80B	$11.29B
Enterprise Value	$10.49B	$11.23B
Price	$366.16	$72.46
P/E Ratio	44.15x	62.64x
P/S Ratio	3.78x	9.29x
EV/Sales	4.05x	9.24x
EV/EBITDA	15.48x	28.63x
P/B Ratio	1.38x	5.39x
P/FCF Ratio	27.75x	42.89x
EV/FCF	29.69x	42.65x
PEG Ratio	N/A	9.81x
Forward P/E (NTM)	33.67x	34.64x
Forward P/S (NTM)	3.70x	8.77x
Revenue & Growth
Revenue (TTM)	$2.59B	$1.22B
Revenue Growth (YoY)	1.4%	-0.4%
Forward Rev Growth	2.9%	9.8%
Profitability
Gross Margin (TTM)	51.9%	66.2%
Operating Margin (TTM)	1.8%	20.7%
EBITDA Margin (TTM)	9.1%	31.6%
Net Margin (TTM)	8.6%	15.0%
FCF Margin (TTM)	13.6%	21.7%
Net Income (TTM)	$222M	$182M
FCF (TTM)	$353M	$263M
EPS (TTM)	$8.29	$1.16
ROE (TTM)	3.1%	8.9%
ROA (TTM)	2.2%	7.1%
ROIC (TTM)	2.7%	8.0%
Financial Health
Cash	$517M	$265M
Debt	$1.20B	$200M
Net Cash/Debt	$-687M	$65M
Current Ratio (TTM)	3.14x	4.55x
Quick Ratio (TTM)	2.18x	3.35x
Debt/Equity (TTM)	0.17x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.29
52W Performance	20.9%	19.6%
YTD Performance	19.9%	21.5%
% from 52W High	-7.6%	-0.3%
% from 52W Low	54.7%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.48x
FCF Yield (TTM)	3.6%	2.3%
Earnings Yield (TTM)	2.3%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	15.0	21.3
EV/GP/RG	1.18	2.28
Ticker research	View BIO research	View TECH research